The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling by C. Giampietro et al.
JCB: Article
JCB 1
The Rockefeller University Press  $30.00
J. Cell Biol.
www.jcb.org/cgi/doi/10.1083/jcb.201501089
Introduction
Endothelial cells (ECs) form the inner lining of blood vessels, 
and one of their most important properties is to separate blood 
from underlying tissues. Their role as a selective permeability 
barrier is mainly achieved through the coordinated opening and 
closure of cell-to-cell junctions. In addition to maintaining ad-
hesion between neighboring cells, junctions play crucial roles 
in transducing chemical and mechanical signals that regulate 
contact-induced inhibition of cell growth, apoptosis, gene ex-
pression, and vessel formation and stability (Vandenbroucke et 
al., 2008; Giampietro et al., 2012; Giannotta et al., 2013).
EC homotypic adhesion is mainly controlled by two types 
of adhesive structures: tight and adherens junctions (AJs; Mc-
Crea et al., 2009; Vestweber et al., 2009; Giannotta et al., 2013). 
The key component of AJs is transmembrane vascular endo-
thelial (VE)–cadherin, an endothelial-specific member of the 
cadherin family. VE-cadherin is physically connected to a large 
number of intracellular partners that mediate its anchorage to 
the actin cytoskeleton and the transfer of signals essential to 
modulate endothelial functions (Vestweber et al., 2009; Dejana 
and Giampietro, 2012). Not surprisingly, changes in the struc-
ture and composition of AJs have profound effects on vascu-
lar permeability as well as on the overall vascular homeostasis 
(Vestweber et al., 2010).
Junctions are dynamic structures whose regulation and 
structural changes strongly impact adhesion strength and tis-
sue plasticity. ECs from different types of vessels and also from 
different organs show differences in junction composition and 
organization (Orsenigo et al., 2012; Kluger et al., 2013).
Recent studies revealed that the cotranscriptional regu-
lator YAP (Yes-associated protein), originally characterized as 
the molecular target of the size-controlling Hippo pathway (Va-
relas, 2014), is a key relay for the transmission of mechanical 
inputs into gene transcriptional programs (Dupont et al., 2011). 
Indeed, multiple signaling pathways integrating biophysical 
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and biochemical cues converge to regulate the activity of YAP 
(Morgan et al., 2013). YAP, in turn, is essential to modulate 
cell proliferation and differentiation, apoptosis, organ size, and 
morphogenesis of various tissues (Zhao et al., 2011). In epithe-
lial tissues, for example, YAP has been shown to be regulated by 
the formation of cell–cell contacts, to be required for contact in-
hibition of cell proliferation (Zhao et al., 2007), and to respond 
to mechanical perturbation of the epithelial sheet (Aragona et 
al., 2013). In all these situations, actin cytoskeletal–based me-
chanical forces have been shown to be the overarching regula-
tor of the activity of YAP and its related molecule TAZ, setting 
responsiveness to a variety of key signaling axes, including the 
Hippo, WNT, and G protein–coupled receptor pathways. Nota-
bly, Yap−/− mice display an early embryonic lethal phenotype 
resulting from defects in yolk sac vasculogenesis, chorioallan-
toic fusion, and embryonic axis elongation (Morin-Kensicki et 
al., 2006), suggesting a role of this protein also in the control of 
endothelial morphogenetic processes. The molecular determi-
nants through which ECs control YAP regulation remain, how-
ever, largely unexplored.
The EGF receptor kinase substrate 8 (EPS8) is a signal-
ing adapter protein involved in the transduction of signal from 
RAS to RAC (Scita et al., 1999). EPS8 also directly binds to 
actin filaments controlling the rate of polymerization/depolym-
erization by capping the fast-growing ends of filaments (Croce 
et al., 2004; Disanza et al., 2004, 2006; Hertzog et al., 2010). 
Consistently, EPS8, in vivo, is required for optimal actin-based 
motility impacting migratory properties of different cells (Frit-
toli et al., 2011). Furthermore, EPS8 regulates the proper ar-
chitectural organization of actin-based structures, including 
intestinal microvilli and stereocilia (Disanza et al., 2006; Hert-
zog et al., 2010; Tocchetti et al., 2010; Manor et al., 2011). One 
Figure 1. EPS8 is a novel component of AJ complexes in ECs. (A) Detection of full-length VE-cadherin–EPS8 interaction by LUM IER (top); the data are 
representative of five independent experiments. Association of EPS8 to full-length VE-cadherin (bottom). Coimmunoprecipitation and Western blot of en-
dogenous VE-cadherin and EPS8 from extract of VE-Cadherin–positive ECs. The dashed line indicates an LIR of 3, a conservative LIR cutoff. (B) Analysis 
of VE-cadherin cytoplasmic tail and EPS8 full-length interaction in vitro by His-tag pull-down assay (left). Analysis of the interaction between VE-cadherin 
cytoplasmic tail and EPS8 deleted mutants (asterisks) in vitro by GST pull-down assay (right). (C) Association of EPS8 to VE-cadherin full-length (VE-cad), 
Δ-p120, and Δ-βcat mutants upon transient expression in COS-1 cells. Cells were transfected with the indicated constructs, immunoprecipitated with specific 
EPS8 antibody or isotype control IgG, and blotted as indicated. (D) IF microscopy of VE-cadherin–positive ECs in early confluent (24 h) conditions. Cells 
were double stained with anti–VE-cadherin (red) and anti-EPS8 (green) antibodies. Junctional EPS8 colocalizing with VE-cadherin (arrows) was detected. 
The dashed outline indicates the magnified area to the right. (E) WB analysis (left) of EPS8 expression levels in various stages of confluence conditions (see 
Materials and methods section). Vinculin is the loading control. IF microscopy (right) of WT lung–derived ECs in various stages of confluence conditions. 
The IF of Eps8− ECs confirmed the specificity of the staining. Cells were stained with anti-EPS8 antibody (green) and DAPI (blue). Bars: (D and E) 20 µm; 
(magnification) 10 µm. IVB, in vitro binding; TOT, total cell lysate.
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additional cellular process in which EPS8 is implicated is the 
regulation of intracellular trafficking of various membrane re-
ceptors (Lanzetti et al., 2000; Di Fiore and Scita, 2002; Auciello 
et al., 2013). EPS8 exerts this function either through its direct 
interaction with the GTPase-activating protein, RN-tre, which 
controls the activity of RAB5, a master regulator of early en-
dosomes (Lanzetti et al., 2000; Di Fiore and Scita, 2002), or by 
interacting with the clathrin-mediated endocytosis machinery 
(Taylor et al., 2012; Auciello et al., 2013).
Here, we identified EPS8 as a novel partner of VE- 
cadherin at AJs. We also found that EPS8 regulates the dynamic 
organization of endothelial junctions and the transduction of in-
tracellular signals by tuning YAP transcriptional activity.
Results
EPS8 is a novel component of 
AJ complexes
To identify novel components of the VE-cadherin signaling 
complex, we set up a LUM IER (luminescence-based mamma-
lian interactome mapping) automated high throughput screen-
ing. This approach is designed for the systematic mapping of 
dynamic protein–protein interaction networks in mammalian 
cells (Barrios-Rodiles et al., 2005). Full-length VE-cadherin 
and Δ-βcat mutant, devoid of the C-terminal interaction domain 
with β-catenin (Fig. 1 C, bottom; Navarro et al., 1995), were 
fused to Renilla luciferase (RL) and coexpressed with a library 
Figure 2. Effect of EPS8 expression on AJ organization and dynamics. (A) WB (left) and qRT-PCR (right) analysis of EPS8 reconstitution in eps8−/− lung– 
derived ECs. Cells were infected with either WT EPS8-GFP (EPS8+) or control GFP (EPS8−) lentiviral vectors. The gene expression level has been represented 
as fold changes ± SEM of three independent experiments. (B) qRT-PCR analysis of VE-cadherin (P = 0.06) and β-catenin (P = 0.07) in EPS8+ and EPS8− 
ECs. For each tested gene, the expression level has been represented as fold changes ± SEM of four independent experiments. (C) WB analysis (left) of 
VE-cadherin and β-catenin expression in extracts of EPS8+ and EPS8− ECs in confluent condition. Vinculin is shown as the loading control. The graph (right) 
represents the WB quantification. Columns are means ± SEM of three independent experiments. The dashed line indicates that relative levels for the Eps8+ 
cells were set to 1. (D) IF microscopy of confluent EPS8+ and EPS8− cells stained with anti–VE-cadherin and –β-catenin antibody. An increase of junctional 
proteins’ distribution is observed in the absence of EPS8. Bar, 20 µm. (E) IP of VE-cadherin from EPS8+ and EPS8− cell extracts followed by WB analysis 
of phosphorylation on serine 665 residue and ubiquitin level (top). Quantifications of three independent experiments are shown as means ± SD at the 
bottom. *, P < 0.05; **, P < 0.01.
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of individual Flag-tagged partners in mammalian HEK293T 
cells. We next assessed the association of VE-cadherin wild-
type (WT) and mutant proteins with Flag-tagged proteins by 
performing a luciferase assay on anti-Flag immunoprecipitates. 
Among a variety of identified interactors, we focused our in-
vestigation on EPS8, which bound full-length VE-cadherin-RL, 
but not Δ-βcat-RL mutant (Fig.  1  A, top). We validated the 
physiological relevance of this association by coimmunopre-
cipitation of endogenous proteins from whole WT EC extracts 
(Fig.  1  A, bottom). In vitro pull-down experiments using re-
combinant purified proteins indicated that EPS8 binds directly, 
through its C-terminal domain, to the C-terminal region of 
the cytoplasmic tail of VE-cadherin (Fig.  1  B). Coimmuno-
precipitation experiments between EPS8 and a set of deletion 
mutants of VE-cadherin corroborated the results obtained 
with LUM IER. EPS8 efficiently bound to WT and a VE-cad-
herin mutant devoid of the interaction domain with p120 (Δ-
p120; Lampugnani et al., 1997) but failed to associate with a 
Δ-βcat VE-cadherin, which binds neither endogenous β-catenin 
nor α-catenin (Fig. 1 C, top), indicating that the region span-
ning amino acids 703–784 of VE-cadherin is indispensable 
for this interaction. Confocal analyses of early confluent WT 
(24 h) ECs showed that EPS8 was enriched along cell-to-cell 
junctions and largely colocalized with VE-cadherin (Fig. 1 D, 
arrows and magnification). Notably, EPS8 expression and junc-
tional localization were down-regulated in long confluent WT 
EC culture (72 h; Fig. 1 E). To confirm the specificity of the 
staining, we also performed immunofluorescence (IF) analy-
sis on early confluent Eps8-null ECs (EPS8−) that consistently 
did not reveal any signal.
EPS8 increases the dynamic turnover of 
VE-cadherin
To gain functional cues into the role of EPS8 in ECs, we derived 
ECs from lungs of eps8-null mice, which were subsequently 
reconstituted with either WT EPS8-EGFP (EPS8+ cells) or con-
trol EGFP (EPS8− cells) lentiviral vectors (Fig. 2 A; Menna et 
al., 2009). EC populations are characterized by high phenotypic 
heterogeneity (Ribatti et al., 2002); thus, we decided to use this 
approach to work with the same cell line, differing only for the 
expression of EPS8. The level of the EPS8 in EPS8+ ECs is 
∼30% more than WT ECs (Fig. S1 A), but this does not sig-
nificantly impact the molecular mechanisms studied, as shown 
in the following paragraph. In the absence of EPS8, the major 
components of the AJ complexes were up-regulated (Fig. 2 C) 
at junctions (Fig. 2 D), but the corresponding mRNAs remained 
unchanged (Fig.  2 B), suggesting a posttranscriptional effect. 
VE-cadherin is internalized through clathrin-mediated path-
ways in a process that requires VE-cadherin phosphorylation 
and ubiquitination (Gavard and Gutkind, 2006; Orsenigo et al., 
2012). Expression of EPS8 increased VE-cadherin phosphory-
lation on serine 665 and ubiquitination (Fig. 2 E), suggesting 
enhanced VE-cadherin turnover.
EPS8 and YAP localization at junctions is 
mutually exclusive
Cadherin complexes can either repress or stimulate gene tran-
scription. Considering the role of EPS8 in cytoskeletal or-
ganization, we asked whether the association of EPS8 with 
VE-cadherin might influence signaling pathways modulated by 
actin remodeling. We focused on the transcriptional cofactor 
YAP because its nuclear-cytoplasmic shuttling and activity may 
be regulated by cadherin-mediated cell–cell contacts (Kim et 
al., 2011) and cytoskeletal-dependent mechanical forces (Du-
pont et al., 2011). YAP was, as shown in other cell types (Ara-
gona et al., 2013), almost entirely localized in the nucleus of 
sparse WT ECs (Fig. 3, A and B). Conversely, in early confluent 
and long confluent WT endothelial monolayers, it was gradu-
ally excluded from the nuclei (Fig. 3, A and B) and redistributed 
along cell-to-cell junctions, where it colocalized with VE-cad-
herin (Fig. 3, A and B). To detect the junctional localization of 
YAP, cells have been fixed with 1% PFA in 2.5-mM triethanol-
amine (see Materials and methods section IF microscopy). In 
vivo, YAP localization at cell–cell junctions was detectable in 
the vessels of the brain and the retina of neonatal mice. Con-
versely, in vessels of other organs such as spleen, kidney, and 
liver, where the junctions are loose, YAP expression at junctions 
was decreased (Fig. 3 C).
Overall, these in vitro and in vivo data suggest that EPS8 
and YAP localize at junctions in a mutually exclusive and 
temporally distinct manner. In particular, EPS8 is a marker 
of early and dynamic junctions, whereas YAP is mostly re-
cruited at stable junctions.
We then asked whether EPS8 might regulate YAP signal-
ing. To this end, we compared EPS8+ to EPS8− ECs in early 
confluent conditions when EPS8 is prominently localized at 
intercellular junctions in WT ECs (Fig. 1 E). Under these con-
ditions, we found that in EPS8− ECs, YAP phosphorylation on 
serine 127, an inhibitory posttranslational modification (Zhao et 
al., 2007), was increased (Fig. 4 A), and YAP nuclear fraction 
was diminished (Fig. 4, B and C) as well as the expression of 
its target genes (Fig. 4 D), whose mRNAs are reduced by ∼10-
fold. Of note, as reported in Fig. S1 B, the expression of YAP 
target genes was significantly high in sparse conditions, and it 
was not affected by the presence or absence of EPS8. YAP tar-
get gene expression was strongly reduced by early cell conflu-
ence as previously published (Schlegelmilch et al., 2011), but 
the reductions were significantly less in the absence of EPS8, 
supporting the idea that EPS8 sustained YAP transcriptional ac-
tivity only when it was localized at AJs (Fig. 1 E).
Inhibition of YAP transcriptional activity 
is mediated by the activation of the 
PI(3)K–Akt pathway upon VE-cadherin 
clustering at AJs
A phosphorylation-dependent “shuttling” between the cyto-
plasm and the nucleus regulates the transcriptional activity of 
Figure 3. YAP is localized at junctions in long confluent monolayers in vitro and in the more stabilized vessels in vivo. (A, top) Confocal microscopy anal-
ysis of YAP (red) colocalization with VE-cadherin (green) and nuclei (DAPI, blue) in WT lung–derived ECs at different stages of confluence conditions (see 
Cell lines in the Materials and methods section). Bar, 20 µm. (A, bottom) Pixels presenting the colocalization of VE-cadherin and YAP are highlighted in 
white. Bars, 10 µm. Nuclei are highlighted with arrowheads, and junctions are highlighted with arrows. (B) Quantification of the number of colocalizing 
pixels between YAP and DAPI (top) or VE-cadherin (bottom) is shown. Data are means ± SEM of three independent experiments. *, P < 0.05; **, P < 0.01. 
(C) Confocal microscopy analysis of Pecam-1 (red) and YAP (green) localization in different organs of P9 mice (top). Bars, 50 µm. Pixels presenting the 
colocalization of Pecam-1 and YAP are highlighted in white. Quantification of the number of colocalizing pixels between YAP and Pecam-1 (bottom). Data 
are means ± SEM of five mice analyzed. *, P < 0.05 for retina, kidney, liver, and spleen versus brain.
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YAP (Varelas, 2014). We found that VE-cadherin expression 
and clustering was important to limit YAP transcriptional ac-
tivity. As reported in Fig. S2 A, and consistent with previously 
published literature (Choi et al., 2015), the up-regulation of YAP 
target genes was severely inhibited in VE-cadherin–positive as 
compared with VE-cadherin–null ECs in confluent conditions. 
VE-cadherin clustering is known to activate Akt through PI(3)
K (Carmeliet et al., 1999; Taddei et al., 2008). Akt, in turn, 
was shown to be able to phosphorylate YAP in serine 127 in 
vitro and in ECs (Basu et al., 2003; Choi et al., 2015). We 
therefore investigated whether EPS8 localization at AJs might 
affect Akt activation and Akt-dependent YAP phosphoryla-
tion. Both Akt and YAP phosphorylation were increased in 
EPS8− cells as compared with EPS8+ cells (Fig. 5 A). Pharma-
cological inhibition of PI(3)K with LY294002 reduced both 
Akt and YAP phosphorylation in EPS8+ and EPS8− cells to a 
comparable level. LY294002 treatment also restored the ex-
pression of YAP-dependent genes in EPS8− ECs to levels sim-
ilar to those observed in EPS8+ cells (Fig. 5 B). Conversely, 
the ectopic expression of myr-Akt, a constitutively active form 
of Akt (Brown et al., 2005), increased the phosphorylation of 
YAP in EPS8+ but not in EPS8− ECs. This lack of effect is 
likely a result of an already high basal AKT phosphoryla-
tion in the latter cell type (Fig. 5 C). myr-Akt infection was 
also able to reduce YAP target gene expression in EPS8+ but 
not EPS8− ECs (Fig. 5 D).
In epithelial cells, YAP transcriptional activity is reduced 
by the organization of E-cadherin–based AJs through the acti-
vation of the Hippo signaling pathway (Kim et al., 2011) and by 
the activity of small GTPases that act primarily through regula-
tion of the actin cytoskeleton (Dupont et al., 2011). Of note, in 
ECs small GTPase activity is controlled by VE-cadherin clus-
tering (Pannekoek et al., 2011; Giannotta et al., 2013; Goddard 
and Iruela-Arispe, 2013). However, neither the Hippo pathway 
(Fig. S3 A) nor the activity of RHO (Fig. S3 B) and RAC1 (Fig. 
S3 C) was altered by removal of EPS8.
Collectively, these data suggest that in ECs inhibition of 
PI(3)K–Akt is the prominent pathway through which EPS8 
increases YAP activity.
Inhibition of YAP transcriptional activity 
is mediated by YAP sequestration by 
α-catenin at AJs
The association of YAP with α-catenin limits its transcriptional 
activity (Silvis et al., 2011). α-Catenin sequesters YAP in the 
cytoplasm, thus preventing its dephosphorylation and nuclear 
translocation (Schlegelmilch et al., 2011; Silvis et al., 2011). 
We investigated whether EPS8 might play a role in the regula-
tion of this pathway. An endogenous YAP–α-catenin complex 
could be detected by coimmunoprecipitation only in EPS8−, 
but not in EPS8+ ECs (Fig. 5 E). This complex associated with 
VE-cadherin as revealed by coimmunoprecipitation experi-
ments (Fig.  5  F), and α-catenin was required for YAP–VE- 
cadherin interaction. Notably, removal of the VE-cadherin 
binding surface for β-catenin, which is required for α-catenin 
binding but not for p120, reduced, as expected, YAP phosphor-
ylation (Fig. S4 A), prevented YAP binding to VE-cadherin 
(Fig. S4 B), and enhanced YAP transcriptional activity (Fig. S4 
C). Finally, silencing of α-catenin impaired YAP localization 
at AJs (Fig. 5 F), reduced YAP phosphorylation (Fig. 5 G), and 
increased its transcriptional activity (Fig. 5 H) in a way more 
marked in the absence than in the presence of EPS8. These 
results suggest that EPS8 restrains the interaction of YAP with 
α-catenin. As a consequence, upon removal of EPS8, YAP is 
more efficiently sequestered into junctional complexes that 
prevent its nuclear translocation and transcriptional activity. 
Of note, and in line with what has been previously published 
(Schlegelmilch et al., 2011; Silvis et al., 2011), we were un-
able to detect a complex between TAZ, the related protein of 
YAP, and α-catenin, suggesting that TAZ activity may be regu-
lated by different mechanisms, but specific studies are required 
to test this hypothesis.
Figure 4. EPS8 expression modulates YAP phosphorylation, localization, and transcriptional activity in confluent ECs. (A) YAP phosphorylation (Phospho- 
YAP serine 127) in confluent EPS8+ and EPS8− cells. Total cell lysates were analyzed by WB for phosphorylated and total YAP expression by using specific 
antibodies. (B, left) WB analysis of nuclear/cytoplasmic distribution of YAP in confluent EPS8+ and EPS8− cells. On EPS8 removal (right), YAP shifted from 
a preferentially nuclear to a preferentially cytoplasmic localization. NP-95 and tubulin were used as nuclear and cytoplasmic markers, respectively. The 
graph on the right represents the quantification of four independent experiments. (C) IF microscopy of YAP (red) nuclear localization (arrowheads) in EPS8+ 
and EPS8− ECs. Bar, 20 µm. (D) qRT-PCR analysis of connective tissue growth factor (Ctgf), Cysteine-rich angiogenic inducer 61 (Cyr61), and Inhibin β A 
(Inhba) in EPS8+ and EPS8− ECs to measure YAP transcriptional activity. The absence of EPS8 strongly inhibited YAP transcriptional activity. For each tested 
gene, the expression level has been represented as fold changes ± SEM of three independent experiments. **, P < 0.01.
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EPS8 and the 14–3-3–YAP complex 
compete for binding to α-catenin
A common mechanism of cytoplasmic retention of nuclear 
proteins is mediated by the binding of 14–3-3 proteins, which 
interact with phosphorylated serine and threonine residues 
(Muslin and Xing, 2000). Consistently, YAP phosphorylated on 
serine 127 interacts with 14–3-3 proteins (Zhao et al., 2007), 
which were also shown to mediate its association with α-catenin 
(Schlegelmilch et al., 2011) in keratinocytes. To assess whether 
a similar complex could be detected in WT ECs, we immuno-
precipitated YAP from EC extracts (36 h of culture). We were 
able to detect a VE-cadherin–α-catenin–14–3-3–YAP complex 
from which EPS8 was excluded (Fig. 6 A). In contrast, α-catenin 
and VE-cadherin, but neither YAP nor 14–3-3 proteins, were re-
covered in EPS8 immunoprecipitates. These results support the 
idea of two different, mutually exclusive pools of VE-cadherin. 
EPS8 may compete with the 14–3-3–YAP complex for the in-
teraction with α-catenin, ultimately controlling YAP activation 
by inhibiting its retention at AJs. We verified this hypothe-
sis using recombinant purified proteins in in vitro pull-down 
Figure 5. YAP phosphorylation and transcriptional activity are regulated through differential PI(3)K–Akt pathway activation and binding to α-catenin. 
(A) WB analysis of YAP and Akt phosphorylation upon inhibition of the PI(3)K–Akt pathway. Cells were grown to 90% confluence, starved for 24 h, and 
incubated overnight in complete medium with the PI(3)K inhibitor LY294002 (10 µM). Vinculin is shown as a loading control. (B) qRT-PCR analysis of 
Cyr61, Ctgf, and Inhba to measure YAP transcriptional activity upon inhibition of PI(3)K in EPS8+ and EPS8− ECs. (C) WB analysis of YAP phosphorylation 
upon overexpression of constitutively active Akt (myr-Akt) in EPS8+ and EPS8− ECs. Vinculin is shown as a loading control. (D) qRT-PCR analysis of Cyr61, 
Ctgf, and Inhba to measure YAP transcriptional activity upon myr-Akt expression in EPS8+ and EPS8− ECs. (E) Coimmunoprecipitation and WB analysis 
of the YAP–α-catenin complex in EPS8+ and EPS8− ECs. (F) IP of VE-cadherin and WB analysis of the YAP–α-catenin complex localization at cell–cell con-
tacts in EPS8+ and EPS8− cells upon specific siRNA of α-catenin. (G) WB analysis of YAP phosphorylation upon specific siRNA of α-catenin in EPS8+ and 
EPS8− ECs. Vinculin is shown as a loading control. (H) qRT-PCR analysis of Ctgf, Cyr61, and Inhba to measure YAP transcriptional activity upon siRNA 
of α-catenin. For each tested gene, the expression level has been represented as fold changes ± SEM of three independent experiments. *, P < 0.05; 
**, P < 0.01. TOT, total cell lysate.
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experiments. We found that EPS8 directly bound α-catenin 
through its N-terminal domain (Fig. 6 B). This latter observa-
tion suggested that EPS8 and the 14–3-3–YAP complex may 
compete for binding to α-catenin. By monitoring the direct as-
sociation of purified α-catenin to immobilized 14–3-3 proteins 
(Schlegelmilch et al., 2011), we found that this interaction was 
abrogated in the presence of an equimolar amount of EPS8 
(Fig. 6 C), supporting the idea of a competition between EPS8 
and 14–3-3–YAP for α-catenin binding.
A critical role of YAP is to release epithelial cells from 
contact inhibition of cell growth (Zhao et al., 2011). This lat-
ter phenomenon is induced by the formation of cadherin junc-
tional complexes that, in addition to physically sequestering 
YAP at junctions (Zhao et al., 2011), also promote YAP phos-
phorylation, further impairing YAP nuclear translocation and 
transcriptional activity (Dupont et al., 2011). The growth inhib-
itory function was ascribed to VE-cadherin in ECs (Caveda et 
al., 1996; Giampietro et al., 2012), suggesting that EPS8 may 
contribute to this effect through the regulation of VE-cadherin 
stability at junctions (Fig. 2) and the consequent modulation of 
YAP localization and activity (Fig. 4).
To provide evidence in this direction, we monitored con-
tact inhibition of cell growth in WT ECs, and we found that 
with the establishment of cell confluence, both Akt and YAP 
increased their phosphorylation level (Fig. 7 A), and in parallel 
YAP transcriptional activity was reduced (Fig.  7  B). Consis-
tently, the removal of EPS8, which both dampens YAP activity 
and increases VE-cadherin localization at junctions, signifi-
cantly reduced the number of confluent cells needed to achieve 
growth arrest (Fig. 7 C).
A correct control of proliferation and the proper estab-
lishment of junctional complexes are the crucial steps for 
the fine regulation of permeability exerted by ECs. Thus, 
we analyzed whether the absence of Eps8 and the conse-
quent alteration in the transcriptional activity of YAP could 
impact the regulation of permeability. We found that Eps8− 
ECs displayed increased permeability compared with Eps8+ 
ECs (Fig. 7 D). EPS8 is therefore emerging as a key induc-
tor of YAP activity that acts both by preventing Akt-depen-
dent phosphorylation of YAP, as well as by restraining the 
binding of the 14–3-3–YAP complex to α-catenin, allowing 
YAP nuclear translocation.
These EPS8 activities are novel and unrelated to its 
well-established role in remodeling actin cytoskeleton. Indeed, 
ECs expressing an EPS8 mutant devoid of actin capping and 
bundling functions (Hertzog et al., 2010) showed a YAP ac-
tivity almost equal to EPS8+-expressing cells as measured by 
serine 127 phosphorylation levels (Fig. 8 A) and by the induc-
tion of target gene expression (Fig. 8 B). So far, we have deci-
phered a new molecular mechanism (Fig. 8 C) through which 
EPS8, a novel partner of VE-cadherin, is able to modulate YAP 
transcriptional activity.
The absence of EPS8 alters YAP 
activity in vivo
To confirm the in vivo relevance of the mechanisms described 
in the previous paragraphs, we analyzed YAP nuclear local-
ization in vessels of WT and eps8-null mice. Consistent with 
what we previously observed, YAP nuclear localization was 
increased in the vasculature of eps8-null mice (Fig. 9, A and 
B). Furthermore, freshly isolated ECs obtained from eps8-null 
mice showed ∼30% reduction of YAP target gene expression 
compared with WT mice (Fig. 9 C). Finally, in agreement with 
cultured cells, the absence of eps8 increased VE-cadherin local-
ization at AJs in vivo too (Fig. 10 A).
To test whether the observed defects in permeability 
shown in cultured ECs were also present in vivo, we tested 
small- and large-size tracers (cadaverine–Alexa Fluor 555 
and 0.1-µm-diameter green fluorescent microsphere, respec-
tively) in WT and eps8-null mice (Figs. 10 B and S5). The 
analysis revealed a specific increase (∼30%) in the accumu-
lation of cadaverine in the parenchyma of brain and lungs 
in eps8-null mice (Fig.  10  B), whereas no difference in 
the extravasation of the high-size green fluorescent micro-
spheres was found (Fig. S5).
Collectively, these findings support the idea that the sig-
naling mechanisms uncovered by in vitro analyses are present 
also in vivo, and Eps8 plays a role in controlling permeability, 
but only to small molecular size tracers.
Figure 6. EPS8 and 14–3-3–YAP complex compete for binding to α- 
catenin. (A) IP of YAP or EPS8 from VE-cadherin–positive cell extracts fol-
lowed by WB analysis of α-catenin, 14–3-3, and VE-cadherin association. 
EPS8 and YAP–14–3-3 are mutually exclusively bound to VE-cadherin and 
α-catenin. (B) Analysis of the interaction between α-catenin and EPS8- 
deleted mutants (asterisks) in vitro by GST pull-down assay. (C) In vitro 
competition assay between EPS8 and 14–3-3 for binding with α-catenin. 
14–3-3 bound α-catenin in the absence of EPS8, and EPS8 reduced this 
direct interaction in a dose-dependent manner. The dashed lines indicate 
the blot has been cropped. IVB, in vitro binding; TOT, total cell lysate.
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Discussion
Endothelial cell-to-cell junctions not only maintain intercellu-
lar adhesion but also transfer multiple intracellular signals that 
modulate contact inhibition of cell growth, cell polarity, lumen 
formation, and permeability (Dejana et al., 2009; McCrea et al., 
2009). The complexity of VE-cadherin signaling is a result of 
the large number of identified intracellular partners that have 
been shown to be directly or indirectly associated with AJs in 
the endothelium (Dejana and Vestweber, 2013).
These signaling proteins can assemble into distinct types 
of complexes, which would vary in composition in the different 
vessels, stages of development, and even within the same cell. 
Furthermore, VE-cadherin association with one or another part-
ner is reversible and can be spatially and temporally regulated.
We report here the identification of EPS8 as a new partner 
of the VE-cadherin complex in ECs that mediates the transduc-
tion of signals impinging on the regulation of the transcriptional 
coactivator YAP. EPS8 promotes VE-cadherin phosphorylation 
and ubiquitination. These posttranslational modifications in-
variably associate with increased internalization and enhance 
cell surface turnover of VE-cadherin (Gavard and Gutkind, 
2006; Orsenigo et al., 2012). Notably, EPS8 is not a stable 
component of VE-cadherin junctions, but it is transiently and 
rapidly recruited at cell-to-cell contacts during dynamic re-
modeling of junctions in early stages of confluency It is likely, 
therefore, that EPS8 contributes to increase junction dynamics. 
Conversely, EPS8 loss reduces the turnover of VE-cadherin 
and favors its clustering, a condition previously shown to pro-
mote the activation of the PI(3)K–Akt pathway (Carmeliet et 
al., 1999; Taddei et al., 2008). Consistent with our results, Choi 
and Kwon (2015) recently found that YAP subcellular local-
ization and activity in ECs are regulated by the VE-cadherin– 
mediated PI3K–Akt pathway. In keeping with these notions, we 
showed that the removal of EPS8 correlates with an increased 
localization of VE-cadherin at AJs and increased activation of 
the PI(3)K–Akt pathway.
YAP has long been shown to be a direct downstream 
target of Akt (Basu et al., 2003). This posttranslational modi-
fication creates binding sites for 14–3-3 proteins, a family of 
Figure 7. The absence of EPS8 induces earlier contact inhibition of cell growth and impairs EC permeability. (A) WB analysis of Phospho-YAP, YAP, Phos-
pho-Akt, and Akt in WT lung–derived ECs at different stages of confluence conditions. Vinculin is the loading control. (B) qRT-PCR analysis of YAP target 
genes in WT lung–derived ECs at different stages of confluence conditions. Data are means ± SEM of four independent experiments. (C) Cell density 
analysis performed on EPS8+ and EPS8− ECs. Equal numbers of cells were seeded at day 1 and subsequently counted at set time points. In the absence 
of EPS8, VE-cadherin localization is higher, and, consequently, cell–cell contact inhibition of proliferation is increased. Data are means ± SEM of eight 
independent experiments. (D) Paracellular tracer flux assay. Permeability to FITC-dextran (70 kD) was assayed. Data are means ± SEM of three independent 
experiments. At all time values from 60 min onward, Eps8+ ECs were statistically lower than Eps8− ECs. *, P < 0.05; **, P < 0.01.
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phosphoserine-binding proteins, that may retain YAP in the 
cytoplasm, preventing its nucleocytoplasmic trafficking and 
transcriptional activity (Zhao et al., 2007). By associating with 
14–3-3, YAP was shown to bind α-catenin in epithelial cells 
(Schlegelmilch et al., 2011). We report here that this interac-
tion also occurs in ECs, where the loss of EPS8 promotes the 
localization of hyperphosphorylated YAP at AJs in a trimeric 
complex with 14–3-3 and α-catenin.
We also found that EPS8 is able to bind directly to α- 
catenin, competing with the 14–3-3–YAP complex. Coimmu-
noprecipitation experiments show the existence of two differ-
ent, mutually exclusive protein complexes of VE-cadherin at 
AJs: in one complex, VE-cadherin binds α-catenin and EPS8, 
whereas in the other, VE-cadherin binds α-catenin, 14–3-3, 
and YAP. As a consequence, elevation of EPS8 levels inhibits, 
by competition for binding to α-catenin, the formation of the 
YAP–14–3-3–α-catenin protein assembly, ultimately inducing 
YAP nucleocytoplasmic shuttling and transcriptional activity. 
The exclusion of YAP from cell junctions by EPS8 is of par-
ticular relevance under conditions of dynamic remodeling of 
junctions, when endothelial monolayers may not have yet com-
mitted to a full growth arrest.
It was shown that actin cytoskeleton and tensional forces 
can modulate YAP activity (Dupont et al., 2011; Aragona et 
al., 2013). EPS8 is an actin-capping and -bundling protein that 
influences actin dynamics in migratory cells. This function re-
sides in the C-terminal effector region of EPS8. We show here 
that EPS8 can interact with α-catenin through its N-terminal 
domain at junctions in a topological arrangement that would 
enable EPS8 to execute its actin regulatory activity via its free 
effector C-terminal domain. However, the finding that an EPS8 
mutant unable to interact with actin (Hertzog et al., 2010) is 
fully competent in restoring YAP translocation to the nucleus 
in EPS8-null ECs argues against this possibility. Our findings 
reveal, instead, an unexpected way of signaling of Eps8 that is 
apparently independent from its ability to control actin dynam-
ics, but relies on a specific set of protein–protein interactions.
It will be important in future studies to determine the 
mechanism through which EPS8 is only transiently recruited 
to junctions. It is possible that increased tension across junc-
tions is the key initiating cue that translates into the formation 
of a set of specialized complexes required to promote the nec-
essary dynamics and plasticity of otherwise relatively stable 
structures and tissues.
Under in vitro and in vivo conditions, AJs are highly dy-
namic structures. Conditions that perturb this equilibrium might 
also perturb vascular permeability.
In eps8-null mice, VE-cadherin localization is increased 
at cell-to-cell contacts, likely through inhibition of turnover. As 
in cultured cells, eps8-null mice show an increase in vascular 
permeability, and the small-size tracer cadaverin accumulates 
in the parenchyma of different organs. However, large-size 
fluorescent beads did not cross the vessels more efficiently in 
the absence of eps8, suggesting a size-selective impairment of 
permeability. This result is consistent with the fact that eps8-
null mice are viable and fertile and apparently devoid of macro-
scopic vascular abnormalities.
A possible explanation for the absence of a more dramatic 
phenotype is that inactivation of Eps8 may be compensated 
for by other members of the family of related genes (Scita et 
al., 1999). Double and triple knockout of EPS8-related genes 
may clarify this aspect. Alternatively, it is possible that under 
Figure 8. EPS8 modulation of YAP phosphorylation and transcriptional activity is independent from its actin capping and bundling functions. (A) WB 
analysis of YAP phosphorylation in EPS8+, EPS8−, and EPS8ΔB+C ECs. Vinculin is shown as a loading control. (B) qRT-PCR analysis of Ctgf, Cyr61, 
and Inhba in confluent EPS8+, EPS8−, and EPS8ΔB+C cells. Significant differences in YAP transcriptional activity has been detected only in EPS8− ECs. 
For each tested gene, the expression level has been represented as fold changes ± SEM of three independent experiments. *, P < 0.05; **, P < 0.01. 
(C) Suggested model for the regulation of YAP phosphorylation, localization, and transcriptional activity. EPS8 transiently binds VE-cadherin during junctional 
remodeling a) while YAP is localized in the nuclei of ECs; b) when junctions are stabilized, VE-cadherin clustering induces PI(3)K–Akt–YAP phosphorylation 
and, c) consequently, YAP is sequestered at the plasma membrane. a) The transient direct bond of Eps8 to α-catenin prevents that of 14–3-3–phospho-YAP.
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specific pathological conditions, eps8-null mice present alter-
ations that are undetectable in healthy conditions.
In conclusion, we show here that the transient localiza-
tion of EPS8 at endothelial junctions modulates VE-cadherin 
organization and induces YAP nuclear translocation and tran-
scriptional activity. Further studies are required to characterize 
in more detail the relevance of this novel molecular pathway in 
additional in vivo models.
Materials and methods
Cell lines
Murine ECs genetically ablated for Cdh5 (VE-cadherin null) and 
modified to express the human WT VE-cadherin (VE-cadherin 
positive) or VE-cadherin Δ-p120 (lacking aa 621–702 of human 
VE-cadherin cDNA, which correspond to the p120-catenin– 
binding region) and Δ-βcat (lacking aa 703–784 of human VE- 
cadherin cDNA, which correspond to the β-catenin–binding region) 
were obtained and cultured as described previously (Giampietro et 
al., 2012). ECs isolated from lungs (Dong et al., 1997; Balconi et al., 
2000) of eps8-null adult mice were lentivirally infected with EGFP 
alone or EGFP-EPS8 (Menna et al., 2009). For the experiments, 
1,800 cells/cm2 and 42,000 cells/cm2 were seeded to obtain sparse 
and confluent cultures; and 40,000 cells/cm2 were seeded and cul-
tured for 24 h, 36 h, and 72 h to reach different stages of confluency 
(early confluent, confluent, and long confluent, respectively). For all 
ECs of murine origin, the culture medium was DMEM with 20% 
FCS, 2-mM glutamine, 100 U/liter penicillin/streptomycin, 1-mM so-
dium pyruvate, 100 µg/ml heparin (from porcine intestinal mucosa; 
Sigma-Aldrich), and 5 µg/ml EC growth supplement (made from calf 
brain; complete culture medium).
The starving medium was MCDB 131 (Invitrogen) with 1% BSA 
(EuroClone), 2-mM glutamine, 100 U/liter penicillin/streptomycin, 
and 1-mM sodium pyruvate.
The epithelial AD-HEK293 cell line (human embryonic kidney; 
American Type Culture Collection) used for adenoviral production 
was grown in DMEM (Cambrex Bioscience) supplemented with 10% 
FBS (HyClone), 2-mM glutamine, 100 U/liter penicillin/streptomycin, 
and 1-mM sodium pyruvate.
Figure 9. EPS8 expression modulates YAP localization and transcriptional activity in vivo. (A) Confocal microscopy analysis of YAP (white) and VE- 
cadherin (red) localization in paraffin sections of brains of WT and eps8-null P9 mice. Bars: (A) 50 µm; (magnification) 20 µm. The dashed outlines indicate 
the areas magnified below. (B) Quantification of the main intensity of YAP nuclear localization. Data are means ± SEM of six WT and six eps8-null mice 
analyzed. (C) qRT-PCR analysis of Ctgf and Cyr61 expression levels in freshly isolated ECs from WT and eps8-null mice. Data are means ± SEM of five 
WT and five Eps8-null mice analyzed. The levels of Ctgf and Cyr61 expression have been normalized on the amount of VE-cadherin gene expression. 
*, P < 0.05; **, P < 0.01.
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The COS-1 cell line (monkey kidney fibroblast-like cells; Ameri-
can Type Culture Collection) used for transient transfection was grown 
in DMEM supplemented with 10% FBS and 2-mM glutamine. All cells 
were cultured at 37°C in a humidified atmosphere of 5% CO2/air.
Antibodies
For IF, Western blotting, and immunoprecipitation (IP), the follow-
ing antibodies were used: VE-cadherin (C-19) goat (sc-6458; Santa 
Cruz Biotechnology, Inc.); VE-cadherin rat BV13 (ab91064; Abcam; 
Corada et al., 2002); EPS8 mouse (610144; BD); α-tubulin mouse 
(T9026; Sigma-Aldrich); vinculin mouse (V9264; Sigma-Aldrich); 
Ub P4D1 mouse (sc-8017; Santa Cruz Biotechnology, Inc.); pY665-
VE-cadherin rabbit (gift from J. Gavard, Institut Cochin, Paris, France; 
Gavard and Gutkind, 2006); YAP (63.7) mouse (sc-10199; Santa Cruz 
Biotechnology, Inc.; Western blot [WB]); phospho-YAP (serine 127) 
rabbit (4911; Cell Signaling Technology); Rac mouse (610650; BD); 
YAP (H-9) mouse (sc-271134; Santa Cruz Biotechnology, Inc.; IF); 
pan 14–3-3 (K-19) rabbit (sc-629; Santa Cruz Biotechnology, Inc.); 
α-catenin rabbit (C2081; Sigma-Aldrich; WB); α-catenin rabbit 
(2028–1; Epitomics; IP); β-catenin mouse (610154; BD); Mst1 rabbit 
(3682; Cell Signaling Technology); Mst2 rabbit (3681; Cell Signaling 
Technology); phospho-Mst1 (threonine 183)/Mst2 (threonine 180) 
rabbit (3681; Cell Signaling Technology); LATS1 (G-16) goat (sc-
12494; Santa Cruz Biotechnology, Inc.); phospho-LATS1 (serine 909) 
rabbit (9157; Cell Signaling Technology); Akt rabbit (9271; Cell Sig-
naling Technology); phospho-Akt (threonine 308) rabbit (9275; Cell 
Signaling Technology); Pecam-1 (CD31; ab28364; Abcam); HRP-
linked anti-mouse, anti-rat, and anti-rabbit (Cell Signaling Technol-
ogy); HRP-linked anti-goat (Promega); Alexa Fluor 555–conjugated 
donkey anti-mouse and anti-goat (Invitrogen); Alexa Fluor 488– 
conjugated donkey anti-mouse (Invitrogen); and GST (Z-5) rabbit 
(sc-459; Santa Cruz Biotechnology, Inc.).
Quantitative RT-PCR (qRT-PCR) analysis
Total RNA was isolated using the RNeasy mini kit (QIA GEN), and 
1 µg was reverse transcribed with random hexamers (High Capacity 
cDNA Archive kit; Applied Biosystems). cDNA was amplified with the 
TaqMan Gene Expression assay (Applied Biosystems) and a thermocy-
cler (ABI Prism 7900HT; Thermo Fisher Scientific). For any sample, 
the expression level, normalized to the housekeeping genes encoding 
18S, was determined by the comparative threshold cycle method as de-
scribed previously (Spagnuolo et al., 2004).
Figure 10. The absence of EPS8 alters the AJ organization and impairs the correct control of permeability in vivo. (A) Confocal microscopy analysis of 
VE-cadherin (green) localization in cryosections of brains of WT and eps8-null adult (2 mo old) mice (left). Quantification of the main intensity of VE-cadherin 
expression; data are means ± SEM of four WT and four eps8-null mice analyzed. Bars: (A) 50 µm; (magnification) 20 µm. The dashed outlines indicate 
the areas magnified on the right. (B) In vivo permeability assay. Mice were injected with 25 mg/kg cadaverine–Alexa Fluor 555, and 2 h later they 
were sacrificed and their organs were collected. Whole brains and lungs were photographed, and cadaverine was quantified. Bar, 500 µm. The pres-
ence of cadaverine in the organs was expressed in arbitrary units as mean fluorescence. n = 4 for WT and eps8 null. The dashed outline highlights the 
brain area.*, P < 0.05.
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Mice
All procedures involving animals and their care were performed in 
conformity with the guidelines established by the Italian Foundation 
for Cancer Research Institute of Molecular Oncology Foundation– 
European Institute of Oncology Campus Principles of Laboratory Ani-
mal Care (directive 86/609/EEC).
The generation of eps8−/− mice has been described previously 
by Scita et al. (1999). In brief, we isolated mouse genomic eps8 clones 
from a 129SV library (Agilent Technologies). We used a 7-kb XhoI–
XhoI fragment for 5′ homology and a 2.5-kb EcoRV–NotI fragment 
for 3′ homology. A phosphoglycerate kinase–neo cassette replaced 
an exon-containing eps8 genomic 1.7-kb XhoI–EcoRV fragment. The 
eps8 SH3 domain is encoded by two exons, and the targeting construct 
excluded the first and part of the second of these exons. A genomic 
probe, flanking the targeting construct at the 5′ end, was used to de-
tect the WT (2.6 kb) and targeted (9.5 kb) alleles. Of note, this genetic 
lesion resulted in the complete loss of the eps8 gene product as deter-
mined by mRNA analysis and immunoblotting with antipeptide serum 
raised against the N-terminal region of EPS8. Electroporation into 
mouse embryonic day 14 embryonic stem cell clones, and subsequent 
manipulations leading to mice heterozygous and homozygous for the 
mutant Eps8 allele, were performed as described previously (Levéen 
et al., 1994). A targeted embryonic stem cell clone was injected into 
C57BL/6 blastocysts, and germline chimeras and mice heterozygous 
and homozygous for the eps8 mutant allele were derived. DNA analy-
ses, derivation of chimeras, and subsequent identification of germline 
transmission, and mice heterozygous and homozygous for the mutant 
eps8 allele, were described previously (Levéen et al., 1994). eps8-null 
mice were backcrossed for >20 generations to C57BL/6 mice. Age- and 
sex-matched C57BL/6 mice were used as controls.
Intravenous injection of lysine-fixable cadaverine conjugated to 
Alexa Fluor 555 and microsphere
Cadaverine conjugated to Alexa Fluor 555 (3.125 mg/ml in saline) was 
injected intravenously into the tail vein of adult (2 mo old) 25-mg/kg mice 
eps8 null and controls. The circulation time was 2 h. For in situ detection of 
cadaverine, the anesthetized mice were perfused for 1–2 min with HBSS, 
followed by 5 min of perfusion with 4% PFA in PBS, pH 7.2. The organs 
were then removed and postfixed in 4% PFA at 4°C for 5–6 h. Images of 
dissected organs were captured using a stereomicroscope (SZX16; Olym-
pus) equipped with a fluorescence long-pass filter for RFP (excitation, 
530–550 nm; emission, 575 nm). Image acquisition was performed using 
a 1× objective with a total magnification of 0.35×, supported by an RGB 
camera (Digital Sight DS-5Mc; Nikon). The ImageJ open-source software 
(National Institutes of Health) was used for data analysis. The mean fluo-
rescence was calculated as the ratios of the total fluorescence signals to the 
number of pixels in the areas, expressed as arbitrary units.
For in situ detection of microspheres, the anesthetized mice 
were intravenously injected with green fluorescent microspheres (0.1-
µm diameter; 50 ml; Duke Scientific) and then perfused for 1–2 min 
with HBSS, followed by 5 min of perfusion with 4% PFA in PBS, pH 
7.2. The tracheas were then removed and postfixed in 4% PFA at 4°C 
for 1 h and then processed for IF analyses.
Histology and tissue IF
Mouse organs were embedded in optimal cutting temperature com-
pound (Tissue-Tek; Sakura) and snap frozen or embedded in paraffin. 
5-µm-thick sections were cut. Frozen sections were fixed in cold meth-
anol or 4% PFA and subjected to IF. Paraffin sections were subjected to 
IF. Blocking (2 h), primary (overnight), and secondary (3 h) antibodies 
were diluted in PBS with 2% BSA. Sections were then counterstained 
with DAPI and mounted in Vectashield.
Retinal immunohistochemistry
Eyes from WT C57BL/6 postnatal day 9 mice were fixed in 2% PFA 
overnight before retinas were dissected. Retinas were incubated in 5% 
donkey serum, 1% BSA, and 0.5% Triton X-100 in PBS overnight and 
the day after, stained with primary antibodies overnight. Then retinas 
were incubated with fluorophore-conjugated antibodies and mounted 
with ProLong gold (Invitrogen).
IF microscopy
Cells were cultured and then fixed with 4% PFA or, if specified in the 
text, with 1% PFA in 2.5-mM triethanolamine, pH 7.5, containing 0.1% 
Triton X-100 and 0.1% NP-40 to optimize junctional staining. Fixed 
cells were permeabilized and incubated for 30 min in a blocking solu-
tion of PBS with 2% BSA.
Cells were then incubated overnight with primary antibodies 
diluted in blocking buffer. Appropriate secondary antibodies were 
applied on cells for 45 min at RT. Confocal microscopy was per-
formed at RT with a confocal microscope (TCS SP2AOBS; Leica) 
equipped with violet (405-nm laser diode), blue (488 nm; Argon), 
yellow (561 nm; solid state), and red (633 nm; HeNe) excitation 
laser lines before processing with Photoshop (Adobe). Only adjust-
ments of brightness and contrast were used in the preparation of 
the figures. For comparison purposes, different sample images of 
the same antigen were acquired under constant acquisition settings. 
Image acquisition was performed using a 63×/1.4 NA oil immer-
sion objective (HCX PL APO 63× Lbd BL; Leica) with spectral 
detection bands and scanning modalities optimized for removal of 
channel cross talk. Confocal software (Leica) and ImageJ version 
1.33 were used for data analysis.
LUM IER assay
The automated high throughput technology LUM IER to analyze 
dynamic protein–protein interaction networks in mammalian cells 
was performed as previously described (Barrios-Rodiles et al., 
2005). Full-length human VE-cadherin and Δ-βcat mutant were 
C-terminally tagged with RL (VE-cadherin-RL and Δ-βcat-RL). In 
brief, HEK293T cells from a library of 640 3× Flag-tagged cDNAs 
that encode proteins comprised of diverse signaling-associated do-
mains (Miller et al., 2009), plated in dishes, were robotically trans-
fected using PolyFect (QIA GEN). After 48 h, cells were lysed and 
then immunoprecipitated using anti-Flag M2 monoclonal antibody 
(Sigma-Aldrich). Luciferase activity in immunoprecipitates and in 
aliquots of total cell lysates was determined using the Renilla Lucif-
erase Assay system (Promega).
Lung EC isolation
Lungs were excised from mice and digested with collagenase type I 
(Roche) for 2 h at 37°C. The ECs were then separated using Dynabeads 
(Invitrogen) coated with Pecam-1 antibody (BD) according to the man-
ual’s instructions and immediately processed for RNA isolation. cDNA 
synthesis and qRT-PCR were performed as described in the Quantita-
tive RT-PCR (qRT-PCR) analysis section.
Statistical analysis
A Student’s two-tailed unpaired t test was used to determine statistical 
significance. The significance level was set at P < 0.05.
IP
Cells were incubated with 100 µg/ml dithiobis(succinimidyl)propio-
nate (Thermo Fisher Scientific) for 20 min at 37°C and then solubi-
lized in lysis buffer (100-mM Tris-HCl, pH 7.4, 150-mM NaCl, 1% 
Triton X-100, 1% deoxycholic acid, 0.1% SDS, 2-mM CaCl2, and 
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protease/phosphatase inhibitors) on ice for 30 min. Precleared cell 
extracts were subjected to antibody precipitation overnight at 4°C, 
and immune complexes were captured by protein G–Sepharose beads 
(GE Healthcare). Immunoprecipitated material was separated on Tris- 
glycine SDS-PAGE, blotted onto nitrocellulose membrane, and ana-
lyzed by standard methodologies.
Western blotting
Confluent cells were lysed by boiling in a modified Laemmli sam-
ple buffer (2% SDS, 20% glycerol, and 125-mM Tris-HCl, pH 6.8). 
Equal amounts of proteins were loaded on gels, separated by SDS-
PAGE, and transferred to a nitrocellulose membrane (Protran; What-
man). After incubation with primary and HRP-linked secondary 
antibodies, specific bindings were detected by a chemiluminescence 
system (GE Healthcare).
Gelatin-glutaraldehyde cross-linking
To enhance EC adhesion, slides were coated with glutaraldehyde–
cross-linked gelatin as follows. The culture supports were incubated 
for 1 h at RT with 1% gelatin, followed by a cross-linking with 2% glu-
taraldehyde solution for 15 min at RT. The glutaraldehyde was replaced 
by 70% ethanol. After 1 h, five washes with PBS followed by overnight 
incubation with PBS containing 2-mM glycine were performed. Before 
cell seeding, slides were washed five times with PBS.
Paracellular tracer flux analysis
Cells were seeded on 6.5-mm-diameter Transwell permeable supports 
(pore size 0.4 µm; Corning), cultured in complete culture medium, and 
assayed for permeability to FITC-dextran (70 kD; Sigma-Aldrich). 
Next, FITC-dextran was added to the medium of the Transwell apical 
compartment at a concentration of 1 mg/ml. At different times of in-
cubation, a 50-µl aliquot of the medium was collected from the basal 
compartment, and the paracellular tracer flux was measured as the 
amount of FITC-dextran in the medium using a fluorometer (Wallac 
Victor3 1420 multilabel counter; PerkinElmer).
Active Rho and Rac pull-down assay
To detect active Rho, we used the Active Rho Pull-Down and Detec-
tion kit (Thermo Fisher Scientific) in accordance with the manufac-
turer’s instructions. To detect active Rac, we used the G-LISA Rac 
activation assay (Cytoskeleton, Inc.) in accordance with the manu-
facturer’s instructions.
Treatments
ECs were starved overnight before any treatment. 10-µM LY294002 
(Cell Signaling Technology) was added overnight at 37°C.
Constructs
A form of Akt that is constitutively active (myr-Akt) was a gift from 
C. Daly (Regeneron Pharmaceuticals Inc., Tarrytown, NY). Cytomeg-
alovirus promoter–based, elongation factor-1 promoter–based eukary-
otic expression vectors, and GST bacterial expression vectors were 
generated by recombinant PCR. His6-tagged α-catenin full-length was 
a gift from B. Weis and W.J. Nelson (Stanford University, Stanford, 
CA). MBP–14–3-3 was procured from GeneCopoeia. All constructs 
were verified by sequencing.
Protein purification
Recombinant full-length His-EPS8, His-Irsp53, and GST-EPS8 
fragments were expressed and purified as previously described 
(Disanza et al., 2006, 2013; Hertzog et al., 2010). In brief, recom-
binant fragments were expressed as His- or GST-fusion proteins 
in the BL21 Escherichia coli strain (Agilent Technologies) and 
affinity purified using GS4B glutathione–Sepharose beads (GE 
Healthcare) or nickel–nitrilotriacetic acid agarose. Eluted proteins 
were dialyzed in 50-mM Tris-HCl, 150-mM NaCl, 1-mM DTT, 
and 20% glycerol. GST–VE-cadherin intracellular domain was ex-
pressed in BL21 Rosetta strain (Agilent Technologies) and affinity 
purified using GS4B glutathione–Sepharose beads. His–α-catenin 
was expressed in the BL21 E.  coli strain (Agilent Technologies) 
and affinity purified using nickel–nitrilotriacetic acid (Ni-NTA) 
agarose according to standard procedures. Recombinant puri-
fied protein was eluted with 200-mM imidazole and dialyzed in 
50-mM Tris, pH 7.8, 150-mM NaCl, 1-mM DTT, and 5% glycerol. 
MBP–14–3-3 was purified by standard procedures using amylose– 
Sepharose affinity purification.
In vitro binding assay
MBP–14–3-3–α-catenin ± EPS8. Recombinant purified proteins were 
incubated overnight at 4°C in Xb buffer (50-mM Tris-HCl, pH 7.4, 
150-mM NaCl, 0.02% Triton X-100, 20-mM imidazole, 1-mM DTT, 
and protease inhibitor cocktail). Samples were then incubated for 1 h 
at 4°C with amylose–Sepharose beads and washed three times with Xb 
buffer. Amylose–Sepharose beads were resuspended in a 1:1 volume of 
2× SDS-PAGE sample buffer, boiled for 5 min at 95°C, spun down for 
1 min, and loaded on acrylamide gels.
EPS8 full-length/VE-cadherin cytoplasmic tail. Recombinant pu-
rified His-EPS8 and VE-cadherin–C-terminal fragment were incubated 
for 1 h at 4°C with Ni-NTA beads in Xa buffer (50-mM Tris, pH 8, 
300-mM NaCl, 0.1% Triton X-100, 20-mM imidazole, 1-mM DTT, 
and protease inhibitor cocktail). Samples were washed three times in 
Xb buffer. Beads were resuspended in a 1:1 volume of 2× SDS-PAGE 
sample buffer, boiled for 5 min at 95°C, spun down for 1 min, and 
loaded on acrylamide gels.
EPS8 fragments/α-catenin full length. Recombinant purified 
GST-EPS8 fragments and His–α-catenin were incubated for 1 h at 4°C 
with Ni-NTA beads in Xb buffer. Samples were washed three times in 
Xb buffer. Beads were resuspended in a 1:1 volume of 2× SDS-PAGE 
sample buffer, boiled for 5 min at 95°C, spun down for 1 min, and 
loaded on acrylamide gels.
EPS8 fragments/VE-cadherin cytoplasmic tail. Equal amounts 
of cell lysates overexpressing VE-cadherin cDNA were incubated with 
GST-EPS8 fragments (GST as control) for 2 h at 4°C in the presence of 
GS4B glutathione–Sepharose beads. Samples were washed three times 
in lysis buffer. Beads were resuspended in a 1:1 volume of 2× SDS-
PAGE sample buffer, boiled for 5 min at 95°C, spun down for 1 min, 
and loaded on acrylamide gels.
RNAi
To interfere with α-catenin, we used siRNA (ON-TAR GETplus 
L-048960-01; SMA RTpool duplex Ctnna1) from GE Healthcare and 
the corresponding nontargeting pool (ONT ARGETplus). Transfection 
was performed with Lipofectamine 2000 (Invitrogen) in accordance 
with the manufacturer’s instructions.
Online supplemental material
Fig. S1 describes EPS8 reconstitution in EPS8− ECs. Fig. S2 shows 
that YAP transcriptional activity is regulated by VE-cadherin. Fig. S3 
shows that EPS8 expression does not influence the Hippo pathway 
and Rho and Rac activity in ECs. Fig. S4 shows that YAP binding 
to VE-cadherin negatively regulates its transcriptional activity. 
Fig. S5 shows the high-size permeability control in vivo. Online 
supplemental material is available at http ://www .jcb .org /cgi /content /
full /jcb .201501089 /DC1.
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Figure S1. EPS8 reconstitution in EPS8− ECs. (A) WB analysis of EPS8 expression levels in EPS8+ and WT lung–derived ECs (left). Vinculin is shown as a 
loading control. Quantification of three independent experiments (right) is shown as means ± SEM. *, P < 0.05. (B) qRT-PCR analysis of Ctgf, Cyr61, and 
Inhba in EPS8+ and EPS8− ECs in sparse and confluent conditions. For each tested gene, the expression level has been represented as fold changes ± SEM 
of three independent experiments. **, P < 0.01.
Figure S2. YAP transcriptional activity is regulated by VE-cadherin. qRT-PCR analysis of Ctgf, Cyr61, and Inhba in VE-cadherin–null and VE-cadherin–
positive ECs to measure YAP transcriptional activity. The expression of VE-cadherin strongly inhibited YAP transcriptional activity. For each tested gene, the 
expression level has been represented as fold changes ± SEM of four independent experiments. **, P < 0.01. VEC, VE-cadherin.
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Figure S3. EPS8 expression does not influence the Hippo pathway signaling and RHO and RAC activity in ECs. (A) WB analysis of the Hippo pathway 
activation. Mst1, Mst2, and LATS1 phosphorylation (Phosho-Mst1 threonine 183, Phospho-Mst2 threonine 180, and Phospho-LATS1 serine 909, respec-
tively) in confluent EPS8+ and Eps8− ECs. (B) Analysis of the Rho GTPase activity by pull-down assay (top) and quantification (bottom) in confluent EPS8+ 
and EPS8− ECs. (C) Analysis of the Rac activation assay (top) in confluent EPS8+ and EPS8− ECs. WB analysis of the total Rac expression levels (bottom). 
Vinculin is shown as a loading control.
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Figure S4. YAP binding to VE-cadherin negatively regulates its transcriptional activity. (A) WB analysis of YAP phosphorylation in ECs expressing full-
length (VE-cadherin positive), Δ-βcat, and Δ-p120 mutants of VE-cadherin. The level of phosphorylation of YAP is reduced in Δ-βcat cells compared with 
that of the other cell lines. (B) IP and WB analysis of the VE-cadherin–Phospho-YAP complex in ECs expressing full-length (VE-cadherin positive), Δ-βcat, and 
Δ-p120 mutants of VE-cadherin. Δ-βcat VE-cadherin did not bind Phospho-YAP (asterisks). (C) qRT-PCR analysis of Ctgf, Cyr61, and Inhba to measure YAP 
transcriptional activity in ECs expressing full-length (VE-cadherin positive), Δ-βcat, and Δ-p120 mutants of VE-cadherin. In Δ-βcat cells, YAP transcriptional 
activity is strongly increased compared with that of the other cell lines. For each tested gene, the expression level has been represented as fold changes ± 
SEM of three independent experiments. **, P < 0.01.
Figure S5. The absence of EPS8 does not impair the correct control of permeability to high-size tracer in vivo. In vivo permeability assay. 2 min before 
fixation, green fluorescent microspheres were intravenously injected. Permeability of the trachea vasculature (Pecam-1; red) has been measured by fluo-
rescent microsphere extravasation (green). Bars, 100 µm. Data are means ± SEM of three WT and three eps8-null mice. A white box indicates the area 
shown in the magnification below. P = 0.54.
